1. 2018
  2. Kamburova, E. G., Wisse, B. W., Joosten, I., Allebes, W. A., van der Meer, A., Hilbrands, L. B., ... Otten, H. G. (2018). Differential effects of donor-specific HLA antibodies in living- versus deceased-donor transplantation. American Journal of Transplantation. DOI: 10.1111/ajt.14709
  3. Talsma, D. T., Katta, K., Ettema, M. A. B., Kel, B., Kusche-Gullberg, M., Daha, M. R., ... Wang, L. (2018). Endothelial heparan sulfate deficiency reduces inflammation and fibrosis in murine diabetic nephropathy. Laboratory Investigation. DOI: 10.1038/s41374-017-0015-2
  4. Parvanova, A., Trillini, M., Podestà, M. A., Iliev, I. P., Ruggiero, B., Abbate, M., ... PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016 (2018). Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): A randomised, double-blind, placebo-controlled, crossover trial. Lancet Diabetes & Endocrinology, 6(1), 27-40. DOI: 10.1016/S2213-8587(17)30359-5
  5. Savonitto, S., Morici, N., Nozza, A., Cosentino, F., Filardi, P. P., Murena, E., ... Grobbee, D. E. (2018). Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes. Diabetes & Vascular Disease Research, 15(1), 14-23. DOI: 10.1177/1479164117735493
  6. 2017
  7. Gant, C. M., Laverman, G. D., Vogt, L., Slagman, M. C. J., Heerspink, H. J. L., Waanders, F., ... Holland Nephrology Study (HONEST) Network (2017). Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels. Bmc nephrology, 18, [370]. DOI: 10.1186/s12882-017-0789-x
  8. Bhambhani, V., Kizer, J. R., Lima, J. A. C., van der Harst, P., Bahrami, H., Nayor, M., ... Ho, J. E. (2017). Predictors and outcomes of heart failure with mid-range ejection fraction. European Journal of Heart Failure. DOI: 10.1002/ejhf.1091
Previous 1 2 3 4 5 6 7 8 ...78 Next

ID: 37499